Poorer patients find thyroid cancer at later stage: study

September 20, 2012
Poorer patients find thyroid cancer at later stage: study
Income-based health disparity needs addressing, researchers say.

(HealthDay)—Poorer people are more likely than the rich to receive a thyroid cancer diagnosis after the disease has progressed to a more advanced stage, according to a new study.

The study was scheduled for presentation Thursday at a meeting of the American Thyroid Association in Quebec City, Canada.

" is an important health indicator for a number of cancers and other diseases," the meeting's program co-chairwoman, Dr. Elizabeth Pearce, of the Boston Medical Center, said in an association news release. "These new data shed light on yet another area—the time of diagnoses—in which there is a need to close the gap on this disparity."

Using a large thyroid cancer registry in Canada, researchers led by Dr. Stan Van Umm, of the Schulich School of Medicine and Dentistry at the University of Western Ontario, analyzed information on the cancer status, sex, age and socioeconomic status of nearly 1,600 patients diagnosed with thyroid cancer between January 1998 and December 2010.

Compared to younger, richer patients, older people and those with a lower average household income were more likely to receive a thyroid after it had progressed. There is, however, a 4 percent annual decline in the odds of being diagnosed with advanced thyroid cancer in old age, which suggests the disease is being detected sooner over time, the researchers said.

The earlier cancer is diagnosed, the easier it is to treat. The U.S. estimates that more than 56,000 Americans will be diagnosed with thyroid cancer this year, and about 1,800 will die of it.

Data and conclusions presented at meetings should be considered preliminary until published in a peer-reviewed medical journal.

Explore further: Have no fear: Most cases of thyroid cancer do not affect survival

More information: The U.S. National Cancer Institute provides more information on thyroid cancer.

Related Stories

Have no fear: Most cases of thyroid cancer do not affect survival

June 11, 2012
Research presented at the Society of Nuclear Medicine's 59th Annual Meeting reveals that patients with differentiated thyroid cancer live as long as people in perfect health, unless they are in the minority and have reached ...

Thyroid cancer treatment varies by hospital, study finds

August 16, 2011
Where thyroid cancer patients go for care plays a large role in whether they receive radioactive iodine treatment, a new study from the University of Michigan Comprehensive Cancer Center finds.

Study suggests obese patients have more advanced, aggressive papillary thyroid cancer

May 21, 2012
A review of medical records of patients treated at an academic tertiary care center suggests that obese patients present to their physicians with more advanced stage and more aggressive forms of papillary thyroid cancer (PTC), ...

African-Americans with thyroid cancer fare worse than whites

June 21, 2011
African-Americans have fewer incidences of thyroid cancer but have a more advanced form of the disease once they receive a diagnosis -- and are more likely to die from it, according to a new study.

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.